Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia

Juhi Ojha, Jackline Ayres, Charla Secreto, Renee Tschumper, Kari Rabe, Daniel Van Dyke, Susan L Slager, Tait Shanafelt, Rafael Fonseca, Neil Elliot Kay, Esteban D Braggio

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Recent high-throughput sequencing and microarray studies have characterized the genetic landscape and clonal complexity of chronic lymphocytic leukemia (CLL). Here, we performed a longitudinal study in a homogeneously treated cohort of 12 patients, with sequential samples obtained at comparable stages of disease. We identified clonal competition between 2 or more genetic subclones in 70% of the patients with relapse, and stable clonal dynamics in the remaining 30%. By deep sequencing, we identified a high reservoir of genetic heterogeneity in the form of several driver genes mutated in small subclones underlying the disease course. Furthermore, in 2 patients, we identified convergent evolution, characterized by the combination of genetic lesions affecting the same genes or copy number abnormality in different subclones. The phenomenon affects multiple CLL putative driver abnormalities, includingmutations in NOTCH1, SF3B1, DDX3X, and del(11q23). This is the first report documenting convergent evolution as a recurrent event in the CLL genome. Furthermore, this finding suggests the selective advantage of specific combinations of genetic lesions for CLL pathogenesis in a subset of patients.

Original languageEnglish (US)
Pages (from-to)492-498
Number of pages7
JournalBlood
Volume125
Issue number3
DOIs
StatePublished - Jan 15 2015

Fingerprint

High-Throughput Nucleotide Sequencing
Genetic Heterogeneity
B-Cell Chronic Lymphocytic Leukemia
Genes
Microarrays
Gene Dosage
Throughput
Longitudinal Studies
Genome
Recurrence

ASJC Scopus subject areas

  • Immunology
  • Biochemistry
  • Hematology
  • Cell Biology

Cite this

Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia. / Ojha, Juhi; Ayres, Jackline; Secreto, Charla; Tschumper, Renee; Rabe, Kari; Van Dyke, Daniel; Slager, Susan L; Shanafelt, Tait; Fonseca, Rafael; Kay, Neil Elliot; Braggio, Esteban D.

In: Blood, Vol. 125, No. 3, 15.01.2015, p. 492-498.

Research output: Contribution to journalArticle

Ojha, Juhi ; Ayres, Jackline ; Secreto, Charla ; Tschumper, Renee ; Rabe, Kari ; Van Dyke, Daniel ; Slager, Susan L ; Shanafelt, Tait ; Fonseca, Rafael ; Kay, Neil Elliot ; Braggio, Esteban D. / Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia. In: Blood. 2015 ; Vol. 125, No. 3. pp. 492-498.
@article{51e6e933c3984868935bd2db16ef9e22,
title = "Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia",
abstract = "Recent high-throughput sequencing and microarray studies have characterized the genetic landscape and clonal complexity of chronic lymphocytic leukemia (CLL). Here, we performed a longitudinal study in a homogeneously treated cohort of 12 patients, with sequential samples obtained at comparable stages of disease. We identified clonal competition between 2 or more genetic subclones in 70{\%} of the patients with relapse, and stable clonal dynamics in the remaining 30{\%}. By deep sequencing, we identified a high reservoir of genetic heterogeneity in the form of several driver genes mutated in small subclones underlying the disease course. Furthermore, in 2 patients, we identified convergent evolution, characterized by the combination of genetic lesions affecting the same genes or copy number abnormality in different subclones. The phenomenon affects multiple CLL putative driver abnormalities, includingmutations in NOTCH1, SF3B1, DDX3X, and del(11q23). This is the first report documenting convergent evolution as a recurrent event in the CLL genome. Furthermore, this finding suggests the selective advantage of specific combinations of genetic lesions for CLL pathogenesis in a subset of patients.",
author = "Juhi Ojha and Jackline Ayres and Charla Secreto and Renee Tschumper and Kari Rabe and {Van Dyke}, Daniel and Slager, {Susan L} and Tait Shanafelt and Rafael Fonseca and Kay, {Neil Elliot} and Braggio, {Esteban D}",
year = "2015",
month = "1",
day = "15",
doi = "10.1182/blood-2014-06-580563",
language = "English (US)",
volume = "125",
pages = "492--498",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "3",

}

TY - JOUR

T1 - Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia

AU - Ojha, Juhi

AU - Ayres, Jackline

AU - Secreto, Charla

AU - Tschumper, Renee

AU - Rabe, Kari

AU - Van Dyke, Daniel

AU - Slager, Susan L

AU - Shanafelt, Tait

AU - Fonseca, Rafael

AU - Kay, Neil Elliot

AU - Braggio, Esteban D

PY - 2015/1/15

Y1 - 2015/1/15

N2 - Recent high-throughput sequencing and microarray studies have characterized the genetic landscape and clonal complexity of chronic lymphocytic leukemia (CLL). Here, we performed a longitudinal study in a homogeneously treated cohort of 12 patients, with sequential samples obtained at comparable stages of disease. We identified clonal competition between 2 or more genetic subclones in 70% of the patients with relapse, and stable clonal dynamics in the remaining 30%. By deep sequencing, we identified a high reservoir of genetic heterogeneity in the form of several driver genes mutated in small subclones underlying the disease course. Furthermore, in 2 patients, we identified convergent evolution, characterized by the combination of genetic lesions affecting the same genes or copy number abnormality in different subclones. The phenomenon affects multiple CLL putative driver abnormalities, includingmutations in NOTCH1, SF3B1, DDX3X, and del(11q23). This is the first report documenting convergent evolution as a recurrent event in the CLL genome. Furthermore, this finding suggests the selective advantage of specific combinations of genetic lesions for CLL pathogenesis in a subset of patients.

AB - Recent high-throughput sequencing and microarray studies have characterized the genetic landscape and clonal complexity of chronic lymphocytic leukemia (CLL). Here, we performed a longitudinal study in a homogeneously treated cohort of 12 patients, with sequential samples obtained at comparable stages of disease. We identified clonal competition between 2 or more genetic subclones in 70% of the patients with relapse, and stable clonal dynamics in the remaining 30%. By deep sequencing, we identified a high reservoir of genetic heterogeneity in the form of several driver genes mutated in small subclones underlying the disease course. Furthermore, in 2 patients, we identified convergent evolution, characterized by the combination of genetic lesions affecting the same genes or copy number abnormality in different subclones. The phenomenon affects multiple CLL putative driver abnormalities, includingmutations in NOTCH1, SF3B1, DDX3X, and del(11q23). This is the first report documenting convergent evolution as a recurrent event in the CLL genome. Furthermore, this finding suggests the selective advantage of specific combinations of genetic lesions for CLL pathogenesis in a subset of patients.

UR - http://www.scopus.com/inward/record.url?scp=84961289235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961289235&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-06-580563

DO - 10.1182/blood-2014-06-580563

M3 - Article

C2 - 25377784

AN - SCOPUS:84961289235

VL - 125

SP - 492

EP - 498

JO - Blood

JF - Blood

SN - 0006-4971

IS - 3

ER -